Antioxidant drugs as modulators of lymphocyte activation in vitro.
Kalsi
J K
JK
Bath Institute For Rheumatic Disease, University of Bath, U.K.
Clay
K
K
Hall
N D
ND
D000975:Antioxidants / Q000494:pharmacology*; D005609:Free Radicals; D006801:Humans; D066298:In Vitro Techniques; D008213:Lymphocyte Activation / Q000187:drug effects*; D009247:NADH, NADPH Oxidoreductases / Q000037:antagonists & inhibitors; D019255:NADPH Oxidases; D009861:Onium Compounds / Q000494:pharmacology; D010100:Oxygen / Q000378:metabolism; D015375:Receptors, Interleukin-2 / Q000187:drug effects / Q000378:metabolism; D013256:Steroids / Q000494:pharmacology; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology
D000975:Antioxidants; D005609:Free Radicals; D009861:Onium Compounds; D015375:Receptors, Interleukin-2; D013256:Steroids; C069980:U 75412E; C007517:diphenyleneiodonium; D009247:NADH, NADPH Oxidoreductases; D019255:NADPH Oxidases; D010100:Oxygen